Cyclic nucleotide phosphodiesterases as drug targets.
Kelly MP, Nikolaev VO, Gobejishvili L, Lugnier C, Hesslinger C, Nickolaus P, Kass DA, Pereira de Vasconcelos W, Fischmeister R, Brocke S, Epstein PM, Piazza GA, Keeton AB, Zhou G, Abdel-Halim M, Abadi AH, Baillie GS, Giembycz MA, Bolger G, Snyder G, Tasken K, Saidu NEB, Schmidt M, Zaccolo M, Schermuly RT, Ke H, Cote RH, Mohammadi Jouabadi S, Roks AJM.
Kelly MP, et al. Among authors: tasken k.
Pharmacol Rev. 2025 May;77(3):100042. doi: 10.1016/j.pharmr.2025.100042. Epub 2025 Jan 22.
Pharmacol Rev. 2025.
PMID: 40081105
Free article.
Review.